Purpose of the procedure
The effect is temporary and varies according to individual anatomy, clinical presentation, and the application area.
Who can be evaluated for this?
Confirmation of diagnosis, symptom severity, functional goals, prior treatments, and accompanying diseases are evaluated together.
What is blepharospasm?
Blepharospasm is a movement disorder characterized by involuntary and repetitive contractions of the muscles around the eyes. Frequent blinking and involuntary eye closure can affect functions such as reading, walking, and driving.
Goal of the treatment
Botulinum toxin aims to reduce the frequency and severity of spasms by temporarily reducing overactive muscles around the eyes. Ocular surface dryness, eyelid position, and visual complaints are also evaluated prior to treatment.
What is checked during follow-up?
In addition to spasm control, complete eye closure, dryness, drooping eyelid, and visual function are monitored. If necessary, an ophthalmological evaluation is added to the treatment plan.
Scientific evidence
This procedure is evaluated based on the temporary regulatory effect of botulinum toxin on neuromuscular or secretory activity. Scientific studies and relevant specialty guidelines support the importance of accurate patient selection and individualized clinical evaluation.
Safety
Pain and bruising may occur at the injection site. Temporary weakness of adjacent muscles may develop depending on the target area. If widespread weakness, difficulty swallowing, or breathing difficulties develop, emergency medical evaluation is required.
Post-procedure considerations
Short-term tenderness or bruising may be seen around the eyes. If dry eyes, incomplete eye closure, significant eyelid drooping, double vision, or a new change in vision develops, contact our clinic. Any individual eye care recommendations should be followed to protect the ocular surface.
Our approach at our Bodrum clinic
We approach the treatment plan not merely as an injection procedure, but in coordination with diagnosis, functional goals, rehabilitation, and, when necessary, relevant specialties. Treatment goals, expected benefits, potential limitations, and risks are addressed in detail during the information process.
Frequently asked questions
Is the effect permanent?
No, it decreases over time.
Is the dose the same for everyone?
No. The administration plan is individualized according to the targeted muscle or gland, anatomy, functional findings, and clinical goals.
References
Based on peer-reviewed botulinum toxin research, systematic reviews, expert consensus statements, and relevant clinical guidelines.
This page is for general informational purposes.
In whom is it evaluated?
In blepharospasm, the goal is to reduce involuntary periocular contractions while simultaneously preserving eyelid closure, visual function, and ocular surface comfort. The evaluation takes into account the distribution of spasms, the extent to which they affect daily function, and accompanying ocular surface complaints.
What is checked during follow-up?
During follow-up, functional changes such as dry eyes, a sensation of incomplete closure, eyelid drooping, or double vision are questioned as much as spasm frequency and severity. By evaluating the effect and side effects together, the subsequent plan is individualized.
Frequently asked questions
Is blepharospasm solely a cosmetic problem?
No. Because involuntary contractions can affect visual function and daily life, the evaluation is function-oriented.
